Autobio Diagnostics Co., Ltd. (SHA:603658)

Autobio Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	232.83	465.37	1,486	1,138	769.4	327.55
Short-Term Investments	-	3,574	2,333	3,141	3,000	3,092
Trading Asset Securities	231.03	3.61	700.57	-	7.34	85.89
Cash & Short-Term Investments	463.87	4,043	4,521	4,278	3,777	3,505
Cash Growth	-70.69%	-10.57%	5.66%	13.27%	7.75%	303.80%
Accounts Receivable	1,122	1,177	1,181	1,074	1,003	958.87
Other Receivables	26	110.74	24.25	34.86	31.69	45.27
Receivables	1,148	1,288	1,206	1,109	1,035	1,004
Inventory	1,171	1,153	778.29	752.3	589.34	475.52
Other Current Assets	3,680	59.25	108.54	113.63	156.62	109.75
Total Current Assets	6,462	6,543	6,613	6,254	5,558	5,095
Property, Plant & Equipment	3,953	3,982	3,883	3,293	2,864	2,276
Long-Term Investments	178.48	172.54	123.31	13.76	1.72	83.42
Goodwill	164.65	164.65	164.65	164.65	164.65	164.65
Other Intangible Assets	131.61	136.09	179.03	203.27	227.85	252.2
Long-Term Deferred Tax Assets	340.5	335.66	274.61	238.73	201.76	157.83
Long-Term Deferred Charges	111.47	382.71	179.23	169.97	137.11	104.66
Other Long-Term Assets	625.83	158.7	137.55	135.59	78.07	3.21
Total Assets	11,968	11,875	11,554	10,472	9,233	8,137
Accounts Payable	1,298	1,135	726.15	1,010	355.24	438.73
Accrued Expenses	60.77	349.51	364.54	335.93	238.07	161.57
Short-Term Debt	322	240.21	353.28	113.84	121.39	206.63
Current Portion of Long-Term Debt	10.52	285	342	-	100.08	-
Current Portion of Leases	-	8.34	10.93	12.56	9.78	-
Current Income Taxes Payable	162.35	102.38	137.85	86.48	77.62	28.95
Current Unearned Revenue	60.66	166.11	148.14	135.48	125.1	95.86
Other Current Liabilities	547.66	372.71	400.25	472.27	431.28	325.19
Total Current Liabilities	2,462	2,660	2,483	2,167	1,459	1,257
Long-Term Leases	19.58	20.63	24.64	16.26	26.16	-
Long-Term Unearned Revenue	237.07	214.65	118.98	101.77	75.68	58.29
Long-Term Deferred Tax Liabilities	274.72	284.19	258.03	273.03	269.1	236.61
Other Long-Term Liabilities	4.68	4.25	2.92	2.22	-	-
Total Liabilities	2,998	3,183	2,888	2,560	1,829	1,552
Common Stock	571.42	581.01	586.27	586.27	586.27	450.98
Additional Paid-In Capital	3,358	3,819	4,101	4,101	4,101	4,250
Retained Earnings	4,946	4,676	4,091	3,338	2,590	1,771
Treasury Stock	-	-461.03	-243.3	-243.3	-	-
Comprehensive Income & Other	1.12	1.14	1.03	0.61	-0.07	5.25
Total Common Equity	8,877	8,617	8,535	7,783	7,277	6,477
Minority Interest	92.92	75.27	130.87	129.59	126.49	107.95
Shareholders' Equity	8,970	8,692	8,666	7,912	7,403	6,585
Total Liabilities & Equity	11,968	11,875	11,554	10,472	9,233	8,137
Total Debt	352.1	554.19	730.85	142.66	257.4	206.63
Net Cash (Debt)	111.76	3,488	3,790	4,136	3,520	3,299
Net Cash Growth	-86.49%	-7.95%	-8.37%	17.50%	6.70%	20626.03%
Net Cash Per Share	0.19	6.05	6.54	7.08	6.00	5.91
Filing Date Shares Outstanding	571.42	576.91	581.01	581.01	586.27	586.27
Total Common Shares Outstanding	571.42	576.91	581.01	581.01	586.27	586.27
Working Capital	4,000	3,883	4,130	4,087	4,099	3,838
Book Value Per Share	15.53	14.94	14.69	13.39	12.41	11.05
Tangible Book Value	8,581	8,316	8,192	7,415	6,884	6,061
Tangible Book Value Per Share	15.02	14.41	14.10	12.76	11.74	10.34
Buildings	-	1,895	1,152	829.25	473.02	472.47
Machinery	-	2,916	2,740	2,492	2,283	1,892
Construction In Progress	-	987.28	1,591	1,272	1,105	641.8

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.